scholarly journals APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade

2019 ◽  
Vol 12 (1) ◽  
pp. 45 ◽  
Author(s):  
Debolina Ganguly ◽  
Chun Cai ◽  
Michelle Sims ◽  
Chuan Yang ◽  
Matthew Thomas ◽  
...  

Glioblastoma (GBM) is the most common and deadliest primary adult brain tumor. Invasion, resistance to therapy, and tumor recurrence in GBM can be attributed in part to brain tumor-initiating cells (BTICs). BTICs isolated from various patient-derived xenografts showed high expression of the poorly characterized Apelin early ligand A (APELA) gene. Although originally considered to be a non-coding gene, the APELA gene encodes a protein that binds to the Apelin receptor and promotes the growth of human embryonic stem cells and the formation of the embryonic vasculature. We found that both APELA mRNA and protein are expressed at high levels in a subset of brain tumor patients, and that APELA is also expressed in putative stem cell niche in GBM tumor tissue. Analysis of APELA and the Apelin receptor gene expression in brain tumor datasets showed that high APELA expression was associated with poor patient survival in both glioma and glioblastoma, and APELA expression correlated with glioma grade. In contrast, gene expression of the Apelin receptor or Apelin was not found to be associated with patient survival, or glioma grade. Consequently, APELA may play an important role in glioblastoma tumorigenesis and may be a future therapeutic target.


1998 ◽  
Vol 18 (6) ◽  
pp. 3278-3288 ◽  
Author(s):  
Dhaya Seshasayee ◽  
Peter Gaines ◽  
Don M. Wojchowski

ABSTRACT Erythrocyte development has previously been shown to depend upon the expression of the lineage-restricted trans-acting factor GATA-1. Despite predicted roles for this factor during early development, GATA-1-deficient cells in chimeric mice and embryonic stem cell cultures mature to a late proerythroblast stage and express at least certain genes that normally are thought to be regulated by GATA-1 (including erythroid Krüppel-like factor [EKLF] and the erythropoietin [Epo] receptor). Opportunities to test roles for GATA-1 in erythroid gene activation in these systems therefore are limited. In the present study, in an alternate approach to test the function of GATA-1, GATA-1 has been expressed together with the Epo receptor in myeloid FDCW2 cells and the resulting effects on cytokine-dependent proliferation and erythroid gene expression have been assessed. GATA-1 expression at low levels delayed FDCW2ER cell cycle progression at the G1 phase specifically during Epo-induced mitogenesis. Upon expression of GATA-1 at increased levels, proliferation in response to Epo, interleukin-3 (IL-3), and stem cell factor was attenuated and endogenous GATA-1, EKLF and βmaj-globin gene expression was activated. Friend of GATA-1 (FOG) transcript levels also were enhanced, andets-1 and c-mpl but not Epo receptor gene expression was induced. Finally, in FDCW2 cells expressing increased levels of GATA-1 and a carboxyl-terminally truncated Epo receptor, Epo (with respect to IL-3 as a control) was shown to markedly promote globin transcript expression. Thus, novel evidence for select hierarchical roles for GATA-1 and Epo in erythroid lineage specification is provided.





PLoS ONE ◽  
2020 ◽  
Vol 15 (4) ◽  
pp. e0231844
Author(s):  
Philip R. Griffiths ◽  
Stephen J. Lolait ◽  
Aarifah Bijabhai ◽  
Aoife O’Carroll-Lolait ◽  
Julian F. R. Paton ◽  
...  


2005 ◽  
Vol 311 (2) ◽  
pp. 251-264 ◽  
Author(s):  
Carley N. Sauter ◽  
Rebecca L. McDermid ◽  
Amy L. Weinberg ◽  
Tamara L. Greco ◽  
Xiaojie Xu ◽  
...  


2016 ◽  
Vol 01 (03) ◽  
pp. 201-208 ◽  
Author(s):  
Malini Krishnamoorthy ◽  
Brian Gerwe ◽  
Jamie Heimburg-Molinaro ◽  
Rachel Nash ◽  
Jagan Arumugham ◽  
...  


2016 ◽  
Vol 30 (1) ◽  
Author(s):  
A. Runov ◽  
◽  
E Kurchakova ◽  
D Khaschevskaya ◽  
O Moiseeva ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document